BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 9091004)

  • 1. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement and menopausal symptoms following hysterectomy.
    Langenberg P; Kjerulff KH; Stolley PD
    Am J Epidemiol; 1997 Nov; 146(10):870-80. PubMed ID: 9384207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
    Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E
    J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
    Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
    J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women.
    Amigoni S; Morelli P; Chatenoud L; Parazzini F
    Climacteric; 2000 Mar; 3(1):25-32. PubMed ID: 11910606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.
    Hunt K; Vessey M; McPherson K
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1080-6. PubMed ID: 2126197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's health in midlife: the influence of the menopause, social factors and health in earlier life.
    Kuh DL; Wadsworth M; Hardy R
    Br J Obstet Gynaecol; 1997 Aug; 104(8):923-33. PubMed ID: 9255084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database.
    Bromley SE; de Vries CS; Farmer RD
    BJOG; 2004 Apr; 111(4):369-76. PubMed ID: 15008775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of menopausal stage and patterns of hormone replacement therapy use.
    Bastian LA; Couchman GM; Rimer BK; McBride CM; Feaganes JR; Siegler IC
    J Womens Health; 1997 Aug; 6(4):467-75. PubMed ID: 9279835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women.
    McCrohon JA; Adams MR; McCredie RJ; Robinson J; Pike A; Abbey M; Keech AC; Celermajer DS
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):435-41. PubMed ID: 8959082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort.
    Ringa V; Ledésert B; Bréart G
    Osteoporos Int; 1994 Jan; 4(1):16-20. PubMed ID: 8148567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion.
    MacLennan AH; Wilson DH; Taylor AW
    Climacteric; 1998 Mar; 1(1):42-9. PubMed ID: 11907925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hormone replacement therapy in Italian women aged 50-70 years.
    Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
    Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.